VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $431 | -52.4% | 46,000 | +24.7% | 0.00% | -50.0% |
Q2 2023 | $905 | -63.3% | 36,900 | -65.2% | 0.00% | 0.0% |
Q1 2023 | $2,463 | +183.8% | 105,900 | +208.7% | 0.00% | 0.0% |
Q4 2022 | $868 | -99.9% | 34,300 | -21.3% | 0.00% | 0.0% |
Q3 2022 | $840,000 | +8.9% | 43,600 | +43.9% | 0.00% | +33.3% |
Q2 2022 | $771,000 | +15.8% | 30,300 | +17.0% | 0.00% | +50.0% |
Q1 2022 | $666,000 | -23.1% | 25,900 | +25.1% | 0.00% | -33.3% |
Q4 2021 | $866,000 | +2.1% | 20,700 | +6.2% | 0.00% | 0.0% |
Q3 2021 | $848,000 | +52.2% | 19,500 | +65.3% | 0.00% | +50.0% |
Q2 2021 | $557,000 | -7.8% | 11,800 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $604,000 | +91.1% | 11,800 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $316,000 | -44.2% | 11,800 | -28.5% | 0.00% | -50.0% |
Q3 2020 | $566,000 | +183.0% | 16,500 | +236.7% | 0.00% | +100.0% |
Q2 2020 | $200,000 | +207.7% | 4,900 | +157.9% | 0.00% | – |
Q1 2020 | $65,000 | +182.6% | 1,900 | 0.0% | 0.00% | – |
Q4 2019 | $23,000 | – | 1,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
Capital International Investors | 983,300 | $12,365,000 | 0.00% |
Blackstone Inc. | 35,000 | $440,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |